Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

ClinicalTrials.gov ID: NCT02666430

Public ClinicalTrials.gov record NCT02666430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Multi-center, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients: An Extension Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this extension study is to assess the safety and efficacy of Mylan's insulin glargine and Lantus® in T1DM patients.

Study identification

NCT ID
NCT02666430
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mylan Inc.
Industry
Enrollment
127 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 66 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2015 (Actual)
Primary completion
Mar 2017 (Actual)
Completion
Jul 2017 (Actual)
Last update posted
Mar 3, 2022

2015 – 2017

United States locations

U.S. sites
39
U.S. states
18
U.S. cities
39
Facility City State ZIP Site status
Mylan Investigator Site Fresno California 93720 —
Mylan Investigator Site Greenbrae California 94904 —
Mylan Investigator Site La Jolla California 92037 —
Mylan Investigator Site Northridge California 91324 —
Mylan Investigator Site Tustin California 92780 —
Mylan Investigator Site Fort Lauderdale Florida 33312 —
Mylan Investigator Site New Port Richey Florida 34652 —
Mylan Investigator Site Palm Harbor Florida 34684 —
Mylan Investigator Site West Palm Beach Florida 33401 —
Mylan Investigator Site Atlanta Georgia 30318 —
Mylan Investigator Site Columbus Georgia 31904 —
Mylan Investigator Site Idaho Falls Idaho 83404 —
Mylan Investigator Site Crystal Lake Illinois 60012 —
Mylan Investigator Site Springfield Illinois 62711 —
Mylan Investigator Site Des Moines Iowa 50314 —
Mylan Investigator Site Overland Park Kansas 66210 —
Mylan Investigator Site Lexington Kentucky 40503 —
Mylan Investigator Site Billings Montana 59101 —
Mylan Investigator Site Omaha Nebraska 68131 —
Mylan Investigator Site Albany New York 12206 —
Mylan Investigator Site Staten Island New York 10301 —
Mylan Investigator Site Syracuse New York 13210 —
Mylan Investigator Site Asheville North Carolina 28803 —
Mylan Investigator Site Burlington North Carolina 27215 —
Mylan Investigator Site Greenville North Carolina 27834 —
Mylan Investigator Site Morehead City North Carolina 28557 —
Mylan Investigator Site Wilmington North Carolina 28401 —
Mylan Investigator Site Cincinnati Ohio 45236 —
Mylan Investigator Site Mentor Ohio 44060 —
Mylan Investigator Site Chattanooga Tennessee 37411 —
Mylan Investigator Site Austin Texas 78731 —
Mylan Investigator Site Dallas Texas 75231 —
Mylan Investigator Site San Antonio Texas 78258 —
Mylan Investigator Site Ogden Utah 84405 —
Mylan Investigator Site Salt Lake City Utah 84121 —
Mylan Investigator Site Chesapeake Virginia 23321 —
Mylan Investigator Site Renton Washington 98057 —
Mylan Investigator Site Tacoma Washington 98405 —
Mylan Investigator Site Vancouver Washington 98664 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02666430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02666430 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →